Spontaneous rectus sheath hematoma: an analysis of 15 cases



Similar documents
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

DVT/PE Management with Rivaroxaban (Xarelto)

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

Thrombosis and Hemostasis

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Anticoagulants in Atrial Fibrillation

LAMC Reversal Agent Guideline for Anticoagulants Time to resolution of hemostasis (hrs) Therapeutic Options

High Risk Emergency Medicine

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

2.5mg SC daily. INR target mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2.

The author has no disclosures

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

To aid practitioners in prescribing unfractionated heparin and low-molecular-weight heparins to patients.

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Antiplatelet and Antithrombotics From clinical trials to guidelines

The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences

Anticoagulant therapy

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Anticoagulation and Reversal

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

STROKE PREVENTION IN ATRIAL FIBRILLATION

Anticoagulation before and after cardioversion; which and for how long

PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Stroke Risk Scores. CHA 2 DS 2 -VASc. CHA 2 DS 2 -VASc Scoring Table 2

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

Blood products and pharmaceutical emergencies

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery

Duration of Dual Antiplatelet Therapy After Coronary Stenting

New Anticoagulants: When and Why Should I Use Them? Disclosures

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Confirmed Deep Vein Thrombosis (DVT)

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Clinical guidance for MRI referral

New Oral Anticoagulants. How safe are they outside the trials?

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial

Chest Pain. Acute Myocardial Infarction: Differential Diagnosis and Patient Management. Common complaint in ED. Wide range of etiologies

Cardiovascular Disease

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003

Traditional anticoagulants

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

Recommendations on Use of Dabigatran in Atrial Fibrillation

New Anticoagulants: What to Use What to Avoid

Are there sufficient indications for switching to new anticoagulant agents

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Antithrombotic therapy

MANAGING BLEEDING IN THE

1/12/2016. What s in a name? What s in a name? NO.Anti-Coagulation. DOACs in clinical practice. Practical aspects of using

9/5/14. Objectives. Atrial Fibrillation (AF)

A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair

Investor News. Not intended for U.S. and UK media

Bios 6648: Design & conduct of clinical research

0.9% Sodium Chloride injection may be used in most cases.

Service Specification Template Department of Health, updated June 2015

The 50-year Quest to Replace Warfarin: Novel Anticoagulants Define a New Era. CCRN State of the Heart 2012 June 2, 2012

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)

New Anticoagulants for the Treatment of Thromboembolism With a little subplot on superficial thrombophlebitis. Mark Crowther

Venous Thromboembolic Treatment Guidelines

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CLINICAL PRACTICE GUIDELINE: MOBILITY WITH A DEEP VEIN THROMBOSIS (DVT) Page 1 of 10

ECG may be indicated for patients with cardiovascular risk factors

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Brief Comparison of Four Agents

I know my value. Be an active part of your anticoagulation therapy with INR self-monitoring

Recommendations: Other Supportive Therapy of Severe Sepsis*

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM

The Fatal Pulmonary Artery Involvement in Behçet s Disease

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

National Patient Safety Goals Effective January 1, 2015

Backgrounder. Current anticoagulant therapies

3/3/2015. Patrick Cobb, MD, FACP March 2015

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia

Lupus anticoagulant Pocket card

LIVER CANCER AND TUMOURS

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU

Preoperative Laboratory and Diagnostic Studies

East Kent Prescribing Group

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285:

Transcription:

Turkish Journal of Trauma & Emergency Surgery Original Article Ulus Travma Acil Cerrahi Derg 2010;16 (6):532-536 Klinik Çalışma Spontaneous rectus sheath hematoma: an analysis of 15 cases Spontan rektus kılıf hematomu: 15 olgunun analizi Sinan ÇARKMAN, Volkan ÖZBEN, Kağan ZENGİN, Erkan SOMUNCU, Adem KARATAŞ BACKGROUND Spontaneous rectus sheath hematoma (RSH) is an uncommon and frequently misdiagnosed cause of acute abdominal pain. The purpose of this study is to present our experiences in the diagnosis and treatment of spontaneous RSH. METHODS This is a retrospective study of the medical histories of 15 patients admitted to our emergency surgery unit between January 2000 and July 2009 and diagnosed with spontaneous RSH (12 females, 3 males; mean age, 64.5 years; range, 20-79 years). RESULTS All cases presented with acute abdominal pain or abdominal wall mass, or both. Eleven of the cases (73%) had been receiving some form of anticoagulation therapy. The leading indications for anticoagulation and/or anti-platelet therapy were atrial fibrillation in 5 patients (33%) and mitral valve replacement in 3 patients (20%). Diagnosis was made by abdominal ultrasonography and/or computerized tomography in 14 patients (93%). Twelve (80%) of the 15 patients were discharged uneventfully after conservative management following a mean hospital stay of 8.8 days (range, 3-24 days). The mortality rate was 20%. CONCLUSION Spontaneous RSH must be suspected in patients with advanced age who are using anticoagulation medications and present with acute abdominal pain. Early diagnosis permits conservative management and avoids unnecessary surgical interventions. Key Words: Acute abdomen; anticoagulant therapy; diagnosis; rectus sheath hematoma; spontaneous; treatment. AMAÇ Spontan rektus kılıf hematomu (RKH) akut karın ağısının sıklıkla gözden kaçan nadir bir nedenidir. Bu çalışmada, spontan RKH nin tanı ve tedavisindeki tecrübelerimizi sunmayı amaçladık. GEREÇ VE YÖNTEM Bu çalışmada, Ocak 2000-Temmuz 2009 tarihleri arasında acil cerrahi polikliniğine başvuran ve spontan RKH tanısı alan 15 hastanın (12 kadın, 3 erkek; ortalama yaş 64,5 yıl; dağılım 20-79 yıl) tıbbi kayıtları retrospektif olarak incelendi. BULGULAR Tüm olguların başvuru nedeni akut karın ağrısı ve/veya karında kitle idi. Toplam 11 olgu (%73) antikoagülan ve/ veya antiagregan tedavisi almaktaydı. Antikoagülan/antiagregan tedavisin endikasyonları arasında en sık olanları 5 hastada (%33) atriyel fibrilasyon ve 3 hastada (%20) mitral kapak replasmanı yer almakta idi. Tanı 14 olguda (%93) karın ultrasonografisi ve/veya bilgisayarlı tomografi ile kondu. Hastaların 12 si (%80) ortalama 8,8 gün (dağılım 3-24 gün) yatış süresi sonrası konservatif tedavi ile sorunsuz bir şekilde taburcu edildi. Mortalite oranı %20 idi. SONUÇ Akut karın ağrısı ile başvuran ve antikoagülan tedavisi almakta olan ileri yaş hastalarında spontan RKH den şüphe edilmelidir. Erken tanı konservatif tedaviye olanak sağlayarak gereksiz cerrahi girişimleri önler. Anahtar Sözcükler: Akut karın; antikoagülan tedavi; tanı; rektus kılıf hematomu; spontan; tedavi. Department of General Surgery, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey. İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, İstanbul. Correspondence (İletişim): Volkan Özben, M.D. İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Kürsü Sekreterliği, 6. Kat, Cerrahpaşa, Fatih 34098 İstanbul, Turkey. Tel: +90-212 - 588 08 73 Fax (Faks): +90-212 - 414 33 70 e-mail (e-posta): volkanozben@yahoo.co.uk 532

Spontaneous rectus sheath hematoma Rectus sheath hematoma (RSH) is a relatively uncommon condition and often a clinically misdiagnosed cause of acute abdominal pain. It is caused by hemorrhage into the rectus sheath, which is caused by damage to the superior or inferior epigastric arteries or their branches, or by direct damage to the rectus muscle. [1,2] It is usually localized in the lower abdominal wall. [3] Many causes of RSH have been described, including trauma, anticoagulation medications, medication injection, hematological and coagulation disorders, increased abdominal pressure from straining, pregnancy, and hypertension. [1,2,4,5] The most frequent predisposing factor is anticoagulation therapy. Women are more prone to RSH than men. Although most cases are self-limiting, RSH can lead to significant morbidity and its overall mortality rate is reported as 4%. [5] The most commonly presented feature is a painful lower abdominal mass that never crosses the midline. [3] If RSH is suspected, the diagnosis is made on the basis of history, physical examination, ultrasonography (US) and computerized tomography (CT) findings. With early diagnosis and conservative management, surgical intervention can be avoided even with large hematoma. Surgery would be necessary in cases in which hemodynamic stability is not achieved. Early diagnosis is mandatory in order to prevent unnecessary surgical interventions. [6] In this retrospective study, we aimed to report our experiences with 15 cases including the previously reported five cases [2] diagnosed with nontraumatic or spontaneous RSH. MATERIALS AND METHODS We retrospectively reviewed the medical records of patients who had been consecutively registered and diagnosed with RSH at our emergency surgery unit between January 2000 and July 2009. The search yielded 19 potential cases. Four cases were excluded as they had alternate diagnoses such as postsurgical RSH and fall-offs. The demographic data (sex, age at diagnosis Table 1. Clinical characteristics of patients diagnosed with spontaneous RSH No Age/ Past medical Previous Physical INR on Radiological Treatment Hospital Outcome Sex history medication signs admission study stay (d) 1 74/F AF Warfarin Tender mass 1.81 None Surgery (HI) 5 Exitus 2 53/F COPD None Tender mass 1.11 CT Conservative 7 Exitus 3 65/F AF Warfarin Tender mass 1.48 US + CT Conservative 3 Discharged 4 72/F Acute coronary Warfarin Tender mass 2.34 US + CT Conservative 21 Discharged syndrome in both lower Q + peri-umbilicus 5 73/F MVR Warfarin Tender mass 1.96 US + CT Conservative 16 Discharged 6 64/F HT Anti-platelet Tx Mass in right * US + CT Conservative 4 Discharged lower Q 7 77/F AF Anti-platelet Tx Tender mass US Conservative 6 Discharged 8 72/F MVR Warfarin Tender mass 1.80 US + CT Conservative 10 Discharged + LMWH in both lower Q 9 49/F SLE LMWH Tender mass None CT Conservative 24 Discharged 10 79/M MI Warfarin Tenderness 2.39 US + CT Conservative 3 Discharged in left upper Q 11 79/F AVR Warfarin Tender mass 5.09 US Conservative 7 Discharged 12 62/F MVR Warfarin Tenderness None US + CT Conservative 3 Discharged 13 68/M AF LMWH Tender mass None US + CT Conservative 7 Exitus in right upper Q (infected hematoma) 14 60/F AF Warfarin Tender mass 3.5 CT Surgery (HI) 13 Discharged (infected hematoma) 15 20/M Factor VIII deficiency None Mass CT Conservative 5 Discharged * Bleeding time >12 min, Bleeding time >9 min, APTT (activity partial thromboplastin time ) = 154 s (normal range, 26-37 s). LMWH: Low-molecular-weight heparin; AF: Atrial fibrillation; COPD: Chronic obstructive pulmonary disease; HT: Hypertension; MVR: Mitral valve replacement; AVR: Aortic valve replacement; MI: Myocardial infarction; SLE: Systemic lupus erythematosus; HI: Hemodynamic instability; Q: Quadrant; Tx: Treatment. Cilt - Vol. 16 Sayı - No. 6 533

Ulus Travma Acil Cerrahi Derg of RSH), clinical characteristics and comorbid conditions, predisposing medications, and presenting signs and symptoms of the patients were evaluated. International normalized ratio (INR) results, radiological (US and CT) findings, treatment approaches, length of hospital stay, and patient outcomes were also documented. RESULTS Fifteen patients were hospitalized with the diagnosis of spontaneous RSH. The clinical features of the patients are summarized in Table 1. Twelve of the 15 patients were female (80%), with a female to male ratio of 4:1. Their ages ranged from 20 to 79 years (mean age, 64.5 years). All patients presented with either abdominal pain or abdominal wall mass, or both. Hemodynamic instability was detected in 2 patients. A total of 11 patients (73%) were receiving some form of anticoagulation therapy: 8 (53%) were on warfarin alone, 2 (13%) were on low-molecular-weight heparin (LMWH) injections, and 1 was on both warfarin and LMWH. Two patients were receiving anti-platelet (aspirin) treatment. The indications for anticoagulation and/or anti-platelet therapy were atrial fibrillation in 5 (33%) and mitral valve replacement in 3 (20%), and the other indications were aortic valve replacement, myocardial infarction, acute coronary syndrome, hypertension, and systemic lupus erythematosus. Chronic obstructive pulmonary disease in 1 case and factor VIII deficiency in 1 case were also detected. The most common presenting symptom was acute abdominal pain followed by an abdominal wall mass. Physical abdominal examination revealed a tender mass or tenderness in all of the cases. INR ranged from 1.11 to 5.09. The diagnosis was made by abdominal CT (Fig. 1) and/or US in 14 patients (93%), and US was utilized for the follow-up. Thirteen patients (87%) were treated nonsurgically with red blood cells (4-11 units), fresh frozen plasma infusions (4-8 units), and vitamin K as required. Surgical evacuation of large and/or infected hematoma and hemostasis were performed in 2 patients (13%). Mean length of hospital stay was 8.6 days (range, 3-24 days). There were 3 fatal cases with a mortality rate of 20%. DISCUSSION RSH is a rare but well-documented clinical entity with an elusive diagnosis. Clinical presentation, past medical history and previous medications in these patients should be carefully questioned in order to obtain valuable information for the correct diagnosis. RSH demonstrates a female to male ratio of 2-3:1, with the highest incidence in the fifth decade. It accounts for up to 2% of cases of unexplained abdominal pain and may occur more often in the right lower quadrant. [2,5,7,8] The present study includes RSH cases who presented with no apparent abdominal trauma such as surgical trauma or falls. Although we found one young patient with hemophilia A, the mean age was 64.5 years (peak age, 79 years). This may be because older patients are more likely to be receiving anticoagulation and/or anti-platelet therapy. [1] The female to male ratio was 4:1, slightly higher than in the earlier reports. [1,7] Other than blunt abdominal trauma, RSH typically occurs in patients who receive anticoagulant or fibrinolytic treatment and in severe hypocoagulability states such as hemophilia and von Willebrand disease. [9] Hemorrhage is the major complication of anticoagulation therapy. The risk of hemorrhage is correlated with the underlying patient characteristics, intensity of anticoagulation and length of the therapy. A similar risk of bleeding is associated with LMWH [10,11] and anti-platelet (acetylsalicylic acid) therapy. The concurrence of synergic side effects from different anti-thrombotics (a) Fig. 1. The abdominal CT appearance of spontaneous RSH in a female patient who had been taking warfarin prior to hospital admission (a). The hematoma arose from the left rectus muscle (arrow). The urinary bladder (UB) was shifted to the right with the expansion of the hematoma to the intraperitoneal cavity (arrowhead). Following conservative treatment, complete resolution of the hematoma was seen on follow-up CT after 12 months (b). 534 Kasım - November 2010 (b)

Spontaneous rectus sheath hematoma will be a growing clinical problem due to the vulnerability of the aged populations and the increasing incidence of age-related diseases such as thrombosis. [9] In our series, 13 patients (86%) were already on some form of anticoagulation and/or anti-platelet therapy on admission. Thus, we highlight the fact that the use of these drugs even in prophylactic doses requires prudent application and deliberate follow-up during their use, especially in the elderly. Both US and CT have been used as diagnostic aids to differentiate between RSH and any intra-abdominal pathology. [5] US may be useful in the diagnosis of RSH, but with a sensitivity rate ranging from only 70% to 90%. CT is useful in excluding other intraabdominal conditions, and is the gold standard, with 100% sensitivity and specificity. [4,7,12] Magnetic resonance imaging is used for long-standing hematomas whenever there is difficulty in distinguishing between a soft tissue tumor and RSH on the CT scan. [4,13] We identified that the findings on the US and CT reports were diagnostic in all of the cases except for one who needed an emergent surgical evacuation of the hematoma due to hemodynamic instability. Infraumbilical localization of the hemorrhage was detected in the majority of our patients (87%). This can be explained by the anatomy of the rectus abdominis muscle below the arcuate line where the posterior rectus sheath passes anteriorly and allows a greater movement of the lower portion of the muscle but also predisposes to vessel rupture with accumulation of large hematomas. [14] As the lesion is self-limited, most RSH can be treated conservatively with analgesia, the treatment of predisposing conditions and cessation of the anticoagulation. When necessary, the coagulation profile should be corrected with the administration of vitamin K, fresh frozen plasma and protamine sulfate in patients being treated with heparin [2,5,11] or, as in our case, factor VIII replacement in patients with hemophilia A. Recombinant VIIa has also been shown to enhance thrombin generation on already thrombin-activated platelets in the absence of factors VIII and IX. [15] The decision to perform a transfusion depends on the hemodynamic status and the presence of comorbid conditions such as coronary ischemia and severe anemia. Active bleeding can be managed either surgically by evacuating the hematoma and ligating the bleeding vessels, or radiologically with catheter embolization. [5,16] An interesting report by Berná-Serna et al. [6] described the complementary therapeutic role of US in the reabsorption of RSH. RSH is rarely fatal, but clinicians should be aware of this possibility especially in frail elderly patients. The high mortality rate (20%) in our series can be explained by the patients accompanying hemodynamic instability and/or comorbid conditions. In the first case with atrial fibrillation, emergent surgical exploration was done because of the hemodynamic instability of the patient, and the diagnosis of RSH was made; the bleeding vessel was ligated at laparotomy. During the follow-up in the intensive care unit, she died on postoperative day 5 due to myocardial infarction. The second case, who had a history of severe chronic obstructive pulmonary disease, died of nosocomial pneumonia on the 7th day of hospitalization. The third fatal case, for whom surgery was planned because of the subsequent infection of the hematoma, developed symptoms and signs of septic shock. Based on the findings of the present study, we conclude that RSH is a rare but potentially serious problem that can occur particularly in elderly patients on anticoagulation medications. A high index of suspicion, diagnostic vigilance and rapid radiological imaging are important for expeditious conservative management. Surgery should be reserved for cases in whom hemodynamic stability can not be established. REFERENCES 1. Cherry WB, Mueller PS. Rectus sheath hematoma: review of 126 cases at a single institution. Medicine (Baltimore) 2006;85:105-10. 2. Zengin K, Carkman S, Kiliç I, Beken E, Eyüboğlu E. Treatment approaches to rectus sheath hematoma. Ulus Travma Acil Cerrahi Derg 2007;13:55-9. 3. Siu WT, Tang CN, Law BK, Chau CH, Li MK. Spontaneous rectus sheath hematoma. Can J Surg 2003;46:390. 4. Luhmann A, Williams EV. Rectus sheath hematoma: a series of unfortunate events. World J Surg 2006;30:2050-5. 5. Donaldson J, Knowles CH, Clark SK, Renfrew I, Lobo MD. Rectus sheath haematoma associated with low molecular weight heparin: a case series. Ann R Coll Surg Engl 2007;89:309-12. 6. Berná-Serna JD, Sánchez-Garre J, Madrigal M, Zuazu I, Berná-Mestre JD. Ultrasound therapy in rectus sheath hematoma. Phys Ther 2005;85:352-7. 7. Osinbowale O, Bartholomew JR. Rectus sheath hematoma. Vasc Med 2008;13:275-9. 8. Klingler PJ, Wetscher G, Glaser K, Tschmelitsch J, Schmid T, Hinder RA. The use of ultrasound to differentiate rectus sheath hematoma from other acute abdominal disorders. Surg Endosc 1999;13:1129-34. 9. Macías-Robles MD, Peliz MG, Gonzalez-Ordonez AJ. Prophylaxis with enoxaparin can produce a giant abdominal wall haematoma when associated with low doses of aspirin among elderly patients suffering cough attacks. Blood Coagul Fibrinolysis 2005;16:217-9. 10. Rimola J, Perendreu J, Falcó J, Fortuño JR, Massuet A, Branera J. Percutaneous arterial embolization in the management of rectus sheath hematoma. AJR Am J Roentgenol 2007;188:497-502. 11. Berná JD, Zuazu I, Madrigal M, García-Medina V, Fernández C, Guirado F. Conservative treatment of large rectus sheath hematoma in patients undergoing anticoagulant therapy. Abdom Imaging 2000;25:230-4. 12. Moreno Gallego A, Aguayo JL, Flores B, Soria T, Hernández Cilt - Vol. 16 Sayı - No. 6 535

Ulus Travma Acil Cerrahi Derg Q, Ortiz S, et al. Ultrasonography and computed tomography reduce unnecessary surgery in abdominal rectus sheath haematoma. Br J Surg 1997;84:1295-7. 13. Berná JD, Garcia-Medina V, Guirao J, Garcia-Medina J. Rectus sheath hematoma: diagnostic classification by CT. Abdom Imaging 1996;21:62-4. 14. Denard PJ, Fetter JC, Zacharski LR. Rectus sheath hematoma complicating low-molecular weight heparin therapy. Int J Lab Hematol 2007;29:190-4. 15. He S, Blombäck M, Jacobsson Ekman G, Hedner U. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost 2003;1:1215-9. 16. Zissin R, Gayer G, Kots E, Ellis M, Bartal G, Griton I. Transcatheter arterial embolisation in anticoagulant-related haematoma-a current therapeutic option: a report of four patients and review of the literature. Int J Clin Pract 2007;61:1321-7. 536 Kasım - November 2010